Inovio Pharmaceuticals News: INO Stock Slammed 28% by Pause in Covid-19 Vaccine TrialInvestorPlace • 09/28/20
Inovio Forced To Delay Planned Phase 2/3 Testing Of Covid-19 Vaccine; Stock PlummetsInvestors Business Daily • 09/28/20
Inovio Plummets After Planned Phase 2/3 Coronavirus Vaccine Study Put On Partial Clinical HoldBenzinga • 09/28/20
Inovio Pharmaceuticals, Inc. (INO) President & CEO Joseph Kim Presents at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit TranscriptSeeking Alpha • 09/23/20